: FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging, which have demonstrated several advantages over [18F]FDG, especially in the case of low-grade or well-differentiated tumors. We conducted this systematic review to evaluate all the studies where a head-to-head comparison had been performed to explore the potential utility of FAPI tracers in clinical practice. FAPI-based radiopharmaceuticals have shown promising results globally, in particular in detecting peritoneal carcinomatosis, but studies with wider populations are needed to better understand all the advantages of these new radiopharmaceuticals.

Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature / Guglielmo, Priscilla; Alongi, Pierpaolo; Baratto, Lucia; Maria Abenavoli, Elisabetta; Buschiazzo, Ambra; Celesti, Greta; Conte, Miriam; Filice, Rossella; Gorica, Joana; Jonghi-Lavarini, Lorenzo; Lanzafame, Helena; R., Laudicella; Librando, Maria; Linguanti, Flavia; Mattana, Francesco; Miceli, Alberto; Olivari, Laura; Piscopo, Leandra; Romagnolo, Cinzia; Santo, Giulia; Vento, Antonio; Volpe, Fabio; Evangelista, Laura. - In: LIFE. - ISSN 2075-1729. - 13:9(2023). [10.3390/life13091821]

Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature

Miriam Conte;Joana Gorica;FABIO VOLPE;
2023

Abstract

: FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging, which have demonstrated several advantages over [18F]FDG, especially in the case of low-grade or well-differentiated tumors. We conducted this systematic review to evaluate all the studies where a head-to-head comparison had been performed to explore the potential utility of FAPI tracers in clinical practice. FAPI-based radiopharmaceuticals have shown promising results globally, in particular in detecting peritoneal carcinomatosis, but studies with wider populations are needed to better understand all the advantages of these new radiopharmaceuticals.
2023
FDG; PET/CT; PET/MRI; fibroblast activation protein inhibitor (FAPI); hybrid imaging; molecular imaging; new radiotracers; nuclear medicine; theranostics
01 Pubblicazione su rivista::01a Articolo in rivista
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature / Guglielmo, Priscilla; Alongi, Pierpaolo; Baratto, Lucia; Maria Abenavoli, Elisabetta; Buschiazzo, Ambra; Celesti, Greta; Conte, Miriam; Filice, Rossella; Gorica, Joana; Jonghi-Lavarini, Lorenzo; Lanzafame, Helena; R., Laudicella; Librando, Maria; Linguanti, Flavia; Mattana, Francesco; Miceli, Alberto; Olivari, Laura; Piscopo, Leandra; Romagnolo, Cinzia; Santo, Giulia; Vento, Antonio; Volpe, Fabio; Evangelista, Laura. - In: LIFE. - ISSN 2075-1729. - 13:9(2023). [10.3390/life13091821]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1697117
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 3
social impact